Immunotherapy and DNA damage repair combo could target lung cancer
Combination therapy with a CHK1 or PARP inhibitor, with an immune checkpoint inhibitor caused the regression of small cell lung cancer in all mice treated...
List view / Grid view
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
Combination therapy with a CHK1 or PARP inhibitor, with an immune checkpoint inhibitor caused the regression of small cell lung cancer in all mice treated...
18 February 2019 | By Tecan and Ncardia
Ncardia, will discuss the application of human iPSC-derived cell-based assays and high throughput screening for drug discovery and development.
A microscopy assay has shown the repair mechanism involved in the activation of a protein called Rho, used to plug leaky biological barriers in the body...
A method has been developed to reprogram stem cells using the measles virus vector, cutting a four-step process to only one stage...
A novel antiplatelet therapy could help to prevent heart attacks and stroke through preventing the formation of blood clots...
Hydrogels could be used to build organs on chips to test potential medications, with the aim that they could potentially replace animal studies...
Researchers have developed a method using PET imaging along with 18F-fluorofuranylnorprogesterone to analyse the efficacy of breast cancer treatments...
A biomarker that can differentiate between chronic cystitis (inflammation of the bladder) and a non-muscle invasive-type blood cancer could aid diagnosis...
Researchers have suggested that the most widespread human malaria parasite could be studied and possibly treated using genomics...
Arginase 2 could be used as a drug target target to protect vision after optic nerve trauma, as removal of this enzyme decreases retinal neuron death...
Stem cells generated from mice have shown to be functional when transplanted, leading to the possibility of future therapies...
An engineered DNA vaccine that induces a robust and specific immune response against the disease, also provides complete protection...
Small molecule drug discovery has long been the domain of pharmaceutical companies, and that’s not likely to change anytime soon. But there’s a cadre of universities and nonprofit research institutes that have embraced drug development at its earliest stages, in some cases identifying and optimising compounds that target possible disease-driving…
Specific immune cells, such as neutrophils, have been found to aid the progression of cancers, promoting metastasis in tumours...
An online compound library consisting of the structure of over a billion molecules could be the future of drug discovery...